Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23 | 32 | 43 | 244 | 32 | 37 | 52 | 284 | 44 | 66 | 52 | 328 |
| Expenses | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 254 | 38 | 62 | 47 | 293 |
| Operating Profit | 5 | 6 | 4 | 37 | 5 | 8 | 0 | 29 | 6 | 4 | 4 | 35 |
| OPM % | 22% | 18% | 9% | 15% | 15% | 22% | 0.8% | 10% | 14% | 5% | 9% | 11% |
| Other Income | 0 | 3 | 1 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 3 |
| Interest | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 | 5 | 5 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 5 | 3 | 34 | 1 | 4 | 2 | 29 | 5 | 2 | 2 | 33 |
| Tax % | 19% | 17% | 19% | 1% | -3% | 30% | 30% | 2% | 12% | 35% | 100% | 2% |
| Net Profit | 2 | 4 | 3 | 33 | 1 | 3 | 1 | 28 | 5 | 2 | -0 | 32 |
| EPS in Rs | 0.79 | 2.02 | 1.38 | 17.55 | 0.58 | 1.39 | 0.78 | 14.88 | 2.54 | 0.84 | -0.01 | 16.98 |
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 97 | 109 | 230 | 234 | 248 | 268 | 445 | 490 |
| Expenses | 82 | 89 | 193 | 185 | 198 | 217 | 393 | 440 |
| Operating Profit | 15 | 20 | 37 | 49 | 50 | 51 | 52 | 49 |
| OPM % | 15% | 18% | 16% | 21% | 20% | 19% | 12% | 10% |
| Other Income | 1 | 1 | -87 | 1 | 4 | 4 | 14 | 15 |
| Interest | 2 | 4 | 11 | 10 | 9 | 11 | 16 | 17 |
| Depreciation | 5 | 5 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 9 | 12 | -63 | 36 | 42 | 41 | 46 | 43 |
| Tax % | -1% | 4% | 6% | 3% | 5% | 5% | 10% | |
| Net Profit | 9 | 12 | -67 | 35 | 40 | 39 | 42 | 39 |
| EPS in Rs | 5.75 | 7.34 | -35.46 | 18.43 | 20.85 | 20.31 | 21.91 | 20.35 |
| Dividend Payout % | 0% | 0% | -6% | 11% | 10% | 10% | 9% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | 24% | 21% | ||
| Compounded Profit Growth | % | % | 1% | 9% | ||
| Stock Price CAGR | 2% | -15% | -12% | -14% | ||
| Return on Equity | % | 6% | 6% | 5% |
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 19 | 19 | 19 | 19 | 19 |
| Reserves | 30 | 41 | 523 | 554 | 591 | 625 | 661 |
| Borrowings | 11 | 19 | 93 | 105 | 110 | 123 | 138 |
| Other Liabilities | 63 | 82 | 105 | 114 | 160 | 259 | 278 |
| Total Liabilities | 120 | 158 | 739 | 793 | 880 | 1,026 | 1,097 |
| Fixed Assets | 21 | 38 | 245 | 244 | 249 | 250 | 249 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 5 | 5 | 6 | 6 | 6 |
| Other Assets | 99 | 121 | 490 | 543 | 625 | 770 | 842 |
| Total Assets | 120 | 158 | 739 | 793 | 880 | 1,026 | 1,097 |
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 17 | 38 | 75 | 18 | -13 | ||
| Cash from Investing Activity | -20 | -3 | -27 | -4 | 3 | ||
| Cash from Financing Activity | -22 | -2 | -8 | -2 | -4 | ||
| Net Cash Flow | -25 | 34 | 39 | 11 | -13 | ||
| Free Cash Flow | 16 | 36 | 48 | 10 | -16 | ||
| CFO/OP | 54% | 80% | 150% | 37% | -22% |
| Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 70 | 136 | 152 | 139 | 121 | 70 |
| Inventory Days | 587 | 667 | 4,388 | ||||
| Days Payable | 146 | 239 | 586 | ||||
| Cash Conversion Cycle | 487 | 499 | 136 | 3,954 | 139 | 121 | 70 |
| Working Capital Days | 79 | 64 | 427 | 415 | 342 | 321 | 253 |
| ROCE % | 24% | 7% | 7% | 7% | 7% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% | 45.59% |
| FIIs | 0.22% | 0.32% | 0.27% | 0.21% | 0.18% | 0.19% | 0.21% | 0.41% | 0.32% | 0.31% | 0.22% | 0.26% |
| DIIs | 4.37% | 4.37% | 4.37% | 4.37% | 4.37% | 4.37% | 3.94% | 2.25% | 0.76% | 0.01% | 0.01% | 0.01% |
| Public | 49.81% | 49.72% | 49.76% | 49.80% | 49.83% | 49.83% | 50.24% | 51.73% | 53.31% | 54.08% | 54.17% | 54.13% |
| No. of Shareholders | 34,365 | 34,263 | 35,132 | 35,834 | 35,423 | 35,056 | 34,911 | 34,207 | 34,122 | 33,550 | 33,031 | 32,564 |
Fundamentals
Market Cap₹ 269 Cr.
Current Price₹ 142
Stock P/E7.94
Book Value₹ 358
ROCE7.10 %
ROE5.47 %
Dividend Yield1.41 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)21%
Compounded Profit Growth (TTM)9%
Consolidated figures.
Valuation
Market capRs 262 Cr
Enterprise valueRs 329 Cr
P/E (TTM)6.77x
Price to book0.46x
Price to sales0.53x
EV / EBITDA5.10x
EV / EBIT5.44x
EV / sales0.67x
Price to cash flow6.82x
Earnings yield14.77%
Dividend yield1.45%
P/E, 3-year average7.66x
P/B, 3-year average0.61x
Profitability
Operating margin (excl. other income)20.86%
Operating margin (incl. other income)21.10%
EBITDA margin13.16%
Pre-tax margin8.86%
Net profit margin7.90%
Net margin, latest quarter9.82%
ROE6.28%
ROCE7.06%
ROA4.57%
ROE, 3-year average2.19%
ROCE, 3-year average5.38%
ROA, 3-year average-0.66%
ROIC (approx.)9.14%
Tax rate3.18%
Other income / net worth0.10%
Growth
Sales growth (latest year)1.67%
Sales CAGR, 3 years34.12%
Profit CAGR, 3 years56.15%
Sales growth QoQ536.56%
Sales growth YoY (latest quarter)15.76%
Profit growth YoY (latest quarter)14.07%
Per share
EPS (TTM)Rs 20.35
EPS (latest year)Rs 18.43
EPS (latest quarter)Rs 16.98
EPS, 3-year averageRs -3.23
Book value per shareRs 301.60
Sales per shareRs 257.74
Cash flow per shareRs 20.19
Free cash flow per shareRs -8.42
Dividend per share (latest year)Rs 2.00
Dividend per share, 3-year averageRs 2.00
Dividends
Dividend payout10.85%
Dividend payout, 3-year average10.85%
Efficiency
Asset turnover0.30x
Fixed asset turnover0.96x
Inventory turnover0.56x
Inventory days657 days
Debtor days152 days
Debtors turnover2.41x
Creditor days586 days
Cash conversion cycle70 days
Working capital days253 days
Leverage
Total debtRs 105 Cr
Cash and bankRs 38 Cr
Net debtRs 67 Cr
Debt to equity0.18x
Net debt / EBITDA1.04x
Interest coverage3.55x
Current ratio (filing 2026-03-31)1.97x
Quick ratio (filing 2026-03-31)0.83x
Trade payables (filing 2026-03-31)Rs 131 Cr
Owners' fund to total sources72.30%
Debt to assets13.27%
Cash flow
Cash from Operating Activity (latest year)Rs 38 Cr
Cash from Investing Activity (latest year)Rs -3 Cr
Cash from Financing Activity (latest year)Rs -2 Cr
Net Cash Flow (latest year)Rs 34 Cr
Free cash flow (latest year)Rs -16 Cr
FCFE (approx.: FCF + change in debt)Rs -4 Cr
Cash from ops / profit, 5 years1.52x
Sales to cash flow6.10x
Statement figures
Net sales (TTM)Rs 490 Cr
Net sales (latest year)Rs 234 Cr
Sales (latest quarter)Rs 328 Cr
Operating profit excl. other income (latest year)Rs 49 Cr
Operating profit (latest quarter)Rs 35 Cr
Other income (TTM)Rs 15 Cr
EBITDA (TTM)Rs 64 Cr
PBDT (TTM)Rs 47 Cr
Profit before tax (TTM)Rs 43 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 39 Cr
Net profit (latest year)Rs 35 Cr
Net profit (latest quarter)Rs 32 Cr
Depreciation (TTM)Rs 4 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 17 Cr
Cost of goods sold (latest year)Rs 116 Cr
Total expenditure (latest year)Rs 185 Cr
Total income (latest year)Rs 235 Cr
Share capitalRs 19 Cr
ReservesRs 554 Cr
Shareholders' fundsRs 573 Cr
Total assetsRs 793 Cr
Net blockRs 244 Cr
InvestmentsRs 5 Cr
ReceivablesRs 97 Cr
InventoryRs 208 Cr
Other liabilitiesRs 114 Cr
Shares outstanding (crore)1.90
Ownership
Promoter holding45.59% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 6.8 is the lowest in its own 3.4-year history
(median 10.3, low 6.8, high 45.4).
P/B 0.46 is at the 2th percentile (median 5.59).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | NATHBIOGEN | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -8.3% | -2.8% | -5.5 pts |
| 1 month | -9.6% | -6.8% | -2.8 pts |
| 3 months | -17.6% | -7.6% | -10.0 pts |
| 6 months | +6.8% | +0.4% | +6.4 pts |
| 1 year | -18.2% | -9.9% | -8.3 pts |
| 2 years | -36.8% | -13.6% | -23.2 pts |
| 3 years | -34.0% | +14.2% | -48.1 pts |
| 5 years | -57.6% | +27.9% | -85.5 pts |
Red flags
F-score 6 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹328 Cr +15.5% vs Jun 2025.
Net profit ₹32 Cr +14.3%.
Against our estimate for Jun 2026: sales -17.0%, profit +25.6% big beat. Our estimate for Sep 2026: sales Rs 47 Cr, profit Rs 3 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| L T Foods Ltd | 13,987 | 21.8 | 17.6 % |
| KRBL Ltd | 8,840 | 11.7 | 15.2 % |
| Gujarat Ambuja Exports Ltd | 7,419 | 17.7 | 12.5 % |
| TruAlt Bioenergy Ltd | 3,940 | 25.2 | 10.4 % |
| Kaveri Seed Company Ltd | 3,801 | 15.2 | 15.8 % |
| Sanstar Ltd | 2,122 | 48.2 | 5.69 % |
| Amir Chand Jagdish Kumar (Exports) Ltd | 2,091 | 16.9 | 15.7 % |
| GRM Overseas Ltd | 1,632 | 21.3 | 14.0 % |
| AVT Natural Products Ltd | 1,403 | 16.7 | 14.2 % |
| Chamanlal Setia Exports Ltd | 1,401 | 11.2 | 18.2 % |
| Gulshan Polyols Ltd | 1,027 | 6.96 | 18.6 % |
| Regaal Resources Ltd | 909 | 14.0 | 12.0 % |
| Bombay Super Hybrid Seeds Ltd | 893 | 31.1 | 16.0 % |
| True Green Bio Energy Ltd | 622 | 11.6 | 13.8 % |
| Mangalam Global Enterprise Ltd | 533 | 14.4 | 17.0 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-09-11 | Dividend - Rs 2 Per Share | |
| 2025-08-14 | Dividend - Rs 2 Per Share | |
| 2024-08-12 | Annual General Meeting | |
| 2024-08-09 | Dividend - Rs 2 Per Share | |
| 2024-03-07 | Extra- Ordinary General Meeting | |
| 2023-07-04 | Annual General Meeting/Dividend - Rs 2 Per Share | |
| 2022-06-23 | Annual General Meeting/Dividend - Rs 2 Per Share | |
| 2021-08-18 | Annual General Meeting/Dividend - Rs 2 Per Share | |
| 2020-07-16 | Annual General Meeting | |
| 2019-08-01 | Annual General Meeting | |
| 2018-07-26 | Annual General Meeting | |
| 2017-08-14 | Annual General Meeting | |
| 2016-07-19 | Annual General Meeting | |
| 2015-07-30 | Annual General Meeting |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 days
Quick answers
What is the market cap of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd (NATHBIOGEN) has a market capitalisation of Rs 269 Cr. at the 2026-10-01 close.
What is the P/E ratio of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd trades at a P/E of 7.94 on trailing twelve-month profit, at the 2026-10-01 close.
What were Nath Bio-Genes (India) Ltd's latest quarterly results?
In the Jun 2026 quarter, Nath Bio-Genes (India) Ltd sales was Rs 328 Cr (+15.5% vs Jun 2025) and net profit was Rs 32 Cr.
What is the 52-week high and low of Nath Bio-Genes (India) Ltd?
The 52-week high is Rs 204.00 and the 52-week low is Rs 126.15.